Molecular and cellular effects of Auger emitters: 2008–2011

References

• Bailey KE, Costantini DL, Cai Z, Scollard DA, Chen Z, Reilly RM, Vallis KA. 2007. Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron-emitting radiopharmaceutical 111In-DTPA-human epidermal growth factor. The Journal of Nuclear Medicine48:1562–1570.
   PubMed Web of Science ®Google Scholar
• Baranowska-Kortylewicz J. 2011. Intraperitoneal radioimmunotherapy: Auger electron emitters for solid tumors. Immunotherapy3:491–494.
   PubMedGoogle Scholar
• Boudousq V, Ricaud S, Garambois V, Bascoul-Mollevi C, Boutaleb S, Busson M, Quenet F, Golombo P-E, Bardies M, Kotzki P-O, Navarro-Teulon I, Pelegrin A, Pouget J-P. 2010. Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of non-internalizing 125I-labeled monoclonal antiodies. The Journal of Nuclear Medicine51:1748–1755.
   PubMed Web of Science ®Google Scholar
• Cai Z, Pignol J-P, Chan C, Reilly RM. 2010. Cellular dosimetry of 111In using Monte Carlo N-particle computer code: Comparison with analytic methods and correlation with in vitro cytotoxicity. The Journal of Nuclear Medicine51:462–470.
   PubMed Web of Science ®Google Scholar
• Cai Z, Vallis KA, Reilly RM. 2009. Computational analysis of the number, area and density of γH2AX foci in breast cancer cells exposed to 111In-DTPA-hEGF or γ rays using Image J software. International Journal of Radiation Biology85:262–271.
   PubMed Web of Science ®Google Scholar
• Cai Z, Chen Z, Bailey KE, Scollard DA, Reilly RM, Vallis KA. 2008. Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF. The Journal of Nuclear Medicine49:1353–1361.
   PubMed Web of Science ®Google Scholar
• Chrastina A, Schnitzer JA. 2010. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. International Journal of Nanomedicine5:653–659.
   PubMed Web of Science ®Google Scholar
• Cornelissen B, Kersemans V, Darbar S, Thompson J, Shah K, Sleeth K, Hill MA, Vallis KA. 2011a. Imaging DNA damage in vivo using γH2AX-targeted immunoconjugates. Cancer Research71:4539–4549.
   PubMedGoogle Scholar
• Cornelissen B, Darbar S, Hernandez R, Kersemans V, Tullis I, Barber PR, Smart S, Vojnovic B, Reilly RM, Vallis KA. 2011b. ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance 111In-DTPA-hEGF Auger electron radiation therapy. The Journal of Nuclear Medicine52:776–783.
   PubMed Web of Science ®Google Scholar
• Cornelissen B, Vallis KA. 2010. Targeting the nucleus: An overview of Auger electron radionuclide therapy. Current Drug Discovery Technologies7:263–279
   PubMedGoogle Scholar
• Costantini DL, Villani DF, Vallis KA, Reilly RM. 2010a. Methotrexate, paclitaxel, and doxorubinin, radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting 111In-NLS-Trastuzumab. The Journal of Nuclear Medicine51:477–483.
   PubMed Web of Science ®Google Scholar
• Costantini DL, McLarty K, Lee H, Done SJ, Vallis KA, Reilly RM. 2010b. Antitumor effects and normal tissue toxicity of 111In-nuclear localization sequence-Trastuzumab in athymic mice bearing HER- positive human breast cancer xenografts. The Journal of Nuclear Medicine51:1084–1091.
   PubMed Web of Science ®Google Scholar
• Costantini DL, Bateman K, McLarty K, Vallis KA, Reilly RM. 2008. Tratuzumab-resistant breast cancer cells remain sensitive to the Auger electron-emitting radiotherapeutic agent 111In-NLS- Tratuzumab and are radiosensitized by methotrexate. The Journal of Nuclear Medicine49:1498–1505.
   PubMed Web of Science ®Google Scholar
• Ertl HH, Feinendegen LE, Heiniger HJ. 1970. Iodine-125, a tracer in cell biology: Physical proterties and biological aspects. Physics Medicine Biology15: 447–456.
   PubMed Web of Science ®Google Scholar
• Feinendegen LE, Ertl HH, Bond VP. 1971. In: Ebert H, editor. Proceedings of the symposium on biological aspects on radiation quality. Vienna: IAEA. pp 419–430.
   Google Scholar
• Fondell A, Edwards S, Ickenstein LM, Sjoberg S, Carlsson J, Gedda L. 2010. Nuclisome: A novel concept for radionuclide therapy using targeting liposomes. European Journal Nuclear Medicine Molecular Imaging37:114–123.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2000. Hallmarks of cancer. Cell100:57–70.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell144:646–674
   PubMed Web of Science ®Google Scholar
• Hofer KG, Warters RL. 1986. Cell lethality after selective irradiation of the DNA replication fork. Radiation Environment Biophysics24:161–174.
   Google Scholar
• Hofer KG, Prensky W, Hughes WL. 1969. Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxyuridine. Journal of the National Cancer Institute43:763–773.
   PubMedGoogle Scholar
• Hofer KG, Hughes WL. 1971. Radiotoxicity of intranuclear tritium, 125Iodine and 131Iodine. Radiation Research47:94–109.
   PubMed Web of Science ®Google Scholar
• Kassis A. 2011. Molecular and cellular radiobiological effects of Auger emitting radionuclides. Radiation Protection Dosimetry143:2–4.
   Google Scholar
• Kassis AI, Kirichian AM, Wang K, Semnani ES, Adelstein SJ. 2004. Therapeutic potential of 5-[125I]iodo-2′-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis. International Journal of Radiation Biology80:941–946.
   PubMed Web of Science ®Google Scholar
• Kersemans V, Cornelissen B, Minden MD, Brandwein J, Reilly RM. 2008. Drug resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences. The Journal of Nuclear Medicine49:1546–1554.
   PubMedGoogle Scholar
• Kortylewicz ZP, Nearman J, Baranowska-Kortylewicz J. 2009. Radiolabeled 5-iodo-3′-O-(17beta-succinyl-5alpha-androstan-3-one)-2′-deoxyuridine and its 5′-monophosphate for imaging and therapy of androgen receptor-positive cancers: Synthesis and biological evaluation. Journal of Medicinal Chemistry52:5124–5143.
   PubMed Web of Science ®Google Scholar
• Kulberg EB, Wei Q, Capala J, Giusti V, Malmstrom PU, Gedda L. 2005. EFG-receptor targeted liposomes with boronated acridine: Growth inhibition of cultured glioma cells after neutron irradiation. International Journal of Radiation Biology81:621–629.
   PubMedGoogle Scholar
• Lehnert S, Li Y, Bump E, Riddoch B, Chenite A, Shive A. 2011. 125I- iododeoxuridine for the treatment of a brain tumor model: Selection of conditions for optimal effectiveness. The Open Nuclear Medicine Journal3:19–24.
   Google Scholar
• Liu X, Wang Y, Nakamura K, Kawauchi S, Akalin A, Cheng D, Chen L. 2009. Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In. The Journal of Nuclear Medicine50:582–590.
   PubMed Web of Science ®Google Scholar
• Lo HW, Ali-Sayed M, Wu Y, Bartholomeusz G, Hsu SC, Hung MC. 2006. Nuclear-cytoplasmic transport of EGFR involved receptor endocytosis, importin beta1 and CRM1. Journal of Cell Biochemistry98:1570–1583.
   PubMed Web of Science ®Google Scholar
• Meijer AJ. 2008. Amino acid regulation of autophagosome formation. In: Deretic V, editor. Methods in molecular biology. Hatfield, Hertfordshire, UK: Humana Press. Vol. 445: Autophagosomes and phagosome.
   Google Scholar
• Mettivier G, Montesi MC, Curion AS, Lauria A, Marotta M, Russo, P. 2010. High resolution 125I pinhole SPECT imaging of the mouse thyroid with the MediSPECT small animal CDTe scanner. IEEE Transactions on Nuclear Science57:1029–1037.
   Google Scholar
• Morgenroth A, Deisenhofer S, Glatting G, Kunkel F-HG, Dinger C, Zlatopskiy B, Vogg ATJ, Kull T, Reske SN. 2008. Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]Iodo-4′-Thio-2′-Deoxyuridine. Clinical Cancer Research14:7311–7319.
   PubMedGoogle Scholar
• Ndlebe T, Panyutin I, Neumann R. 2010. Analysis of the contribution of charge transport in iodine-125. Radiation Research173:98–109.
   PubMedGoogle Scholar
• Pitula S, Wiebke J. 2004. Quantum chemical investigations on the Auger process induced fragmentation of organic compounds and its significance to DNA irradiation damage. Beiträge zumWissenschaftlichen Rechnen Ergebnisse des Gaststudentenprogramms 2004 des John von Neumann-Instituts für Computing. Nov. 2004.
   Google Scholar
• Pouget J-P, Santoro L, Raymond L, Chouin N, Bardies M, Bascoul- Mollevi C, Huguet H, Azria D, Kotzki P-O, Pelegrin M, Vivers E, Pelegrin A. 2008. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by Auger electrons. Radiation Research170:192–200.
   PubMed Web of Science ®Google Scholar
• Rajon R, Bolch RE, Howell RW. 2011. Lognormal distribution of cellular uptake of radioativity: Monte Carlo simulation of irradiation and cell killing in 3-dimensional populations in carbon scaffolds. The Journal of Nuclear Medicine52:926–933.
   PubMed Web of Science ®Google Scholar
• Reilly RM, Chen P, Wand J, Scollard D, Cameron R, Vallis KA. 2006. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: An Auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. The Journal of Nuclear Medicine47:1023–1031.
   PubMed Web of Science ®Google Scholar
• Sak A, Stuschke, M. 2010. Use of γH2AX and other biomarkers of double-strand breaks during radiotherapy. Seminars in Radiation Oncology20:223–231.
   PubMed Web of Science ®Google Scholar
• Santoro L, Boutaleb S, Garambois V, Bascoul-Mollevi C, Boudousq V, Kotzki P-O, Pelegrin M, Navarro-Teulon I, Pelegrin A, Pouget J-P. 2009. Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis. The Journal of Nuclear Medicine50:2033–2041.
   PubMed Web of Science ®Google Scholar
• Sedlacek O, Hruby M, Studenovsky M, Kucka J, Vetvicka D, Kovar L, Rihova B, Ulbrich K. 2011. Ellipticine-aimed polymer-conjugated auger electron emitter: Multistage organelle targeting approach. Bioconjugate Chemistry22:1194–1201.
   PubMedGoogle Scholar
• Weinberg RA. 2007. The biology of cancer. New York: Garland Sciences, Taylor and Francis Group LLC.
   Google Scholar
• Yasui L, Hofer KG, Warters RL. 1985. Inhomogeneity of the nucleus to 125IUdR cytotoxicity. Radiation Research102:106–118.
   PubMed Web of Science ®Google Scholar
• Zanzonico P. 2011. Cell-level dosimetry and biologic response modeling of heterogeneously distributed radionuclides: A step forward. The Journal of Nuclear Medicine52:845–847.
   PubMedGoogle Scholar